How are you ensuring your next clinical trial results in success?

90% of clinical trials do not hit their primary endpoint; 40% for efficacy failures. With tightened funding markets and higher expectations for generating results faster, the decisions around clinical trials must be right.

With current reductionist approaches, it is difficult to predict what will happen when a drug candidate is tried in patients. The exponentially growing volume of data leads to misinterpretations between different groups and incorrect assumptions and missed opportunities that would benefit from a standardized vehicle for all available data. So where do you start? Together, with a select group of your peers we’ll learn about proven, data-driven approaches to clarify that data, build consensus and make better decisions.

We look forward to seeing you in San Francisco.

Established in 2002, Rosa & Co. is known worldwide for the creation of PhysioPD Research. We help life science companies optimize Clinical Development with a proven biosimulation approach. PhysioPD Research is a powerful component of modern drug development. It is a proven quantitative systems pharmacology (QSP) approach that complements the expertise and experience of researchers and clinicians, guides more effective experimental and trial design and enables a deeper understanding of empirical data. In essence, PhysioPD Research empowers dramatically more effective learning about the connection between drug and disease mechanisms to relevant preclinical and clinical outcomes to support more confident decisions at all stages of research and development. We look forward to introducing you to our "mechanism to market" solutions for your pharmaceutical assets in development.